Toll-Like Receptors as Drug Targets in the Intestinal Epithelium
- 17 November 2021
- book chapter
- Published by Springer Nature
- Vol. 276, 291-314
Abstract
Toll-like receptors (TLRs) receptors are responsible for initiation of inflammatory responses by their recognition of molecular patterns present in invading microorganisms (such as bacteria, viruses or fungi) or in molecules released following tissue damage in disease states. Expressed in the intestinal epithelium, they initiate an intracellular signalling cascade in response to molecular patterns resulting in the activation of transcription factors and the release of cytokines, chemokines and vasoactive molecules. Intestinal epithelial cells are exposed to microorganisms on a daily basis and form part of the primary defence against pathogens by using TLRs. TLRs and their accessory molecules are subject to tight regulation in these cells so as to not overreact or react in unnecessary circumstances. TLRs have more recently been associated with chronic inflammatory diseases as a result of inappropriate regulation, this can be damaging and lead to chronic inflammatory diseases such as inflammatory bowel disease (IBD). Targeting Toll-like receptors offers a potential therapeutic approach for IBD. In this review, the current knowledge on the TLRs is reviewed along with their association with intestinal diseases. Finally, compounds that target TLRs in animal models of IBD, clinic trials and their future merit as targets are discussed.Keywords
This publication has 160 references indexed in Scilit:
- Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 AntibodyClinical Pharmacology & Therapeutics, 2013
- Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptidesMucosal Immunology, 2012
- Interleukin 23 Production by Intestinal CD103+CD11b+ Dendritic Cells in Response to Bacterial Flagellin Enhances Mucosal Innate Immune DefenseImmunity, 2012
- Regulation of the polymeric immunoglobulin receptor by the classical and alternative NF-κB pathways in intestinal epithelial cellsMucosal Immunology, 2011
- Apical TLR ligation of intestinal epithelial cells drives a Th1-polarized regulatory or inflammatory type effector response in vitroImmunobiology, 2011
- Toll-like receptors in inflammatory bowel diseases: A decade laterInflammatory Bowel Diseases, 2010
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- IL‐10‐dependent partial refractoriness to Toll‐like receptor stimulation modulates gut mucosal dendritic cell functionEuropean Journal of Immunology, 2008
- Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cellsNature Cell Biology, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006